Deferred Tax Assets, Net of Valuation Allowance of CLOVER HEALTH INVESTMENTS, CORP. /DE from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: CLOVER HEALTH INVESTMENTS, CORP. /DE quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
CLOVER HEALTH INVESTMENTS, CORP. /DE Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2025 was $3,075,000, a 35% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

CLOVER HEALTH INVESTMENTS, CORP. /DE Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$3,075,000	+$803,000	+35%	31 Dec 2025	10-K	27 Feb 2026	2025	FY
Q4 2024	$2,272,000	+$635,000	+39%	31 Dec 2024	10-K	27 Feb 2026	2025	FY
Q4 2023	$1,637,000	-$1,176,000	-42%	31 Dec 2023	10-K	03 Mar 2025	2024	FY
Q4 2022	$2,813,000	+$1,647,000	+141%	31 Dec 2022	10-K	14 Mar 2024	2023	FY
Q4 2021	$1,166,000	-$538,000	-32%	31 Dec 2021	10-K	01 Mar 2023	2022	FY
Q4 2020	$1,704,000			31 Dec 2020	10-K	28 Feb 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.